Treatment of cachexia using fibroblast cells and products thereof
Summary
USPTO granted patent US12589119B2 to Fibrobiologics, Inc. covering methods and compositions for treating cachexia using immune-modulating fibroblasts. Inventors Pete O'Heeron and Thomas Ichim disclosed compositions including immune-modulating fibroblasts for treatment, amelioration, or prevention of cachexia or inflammation related to cachexia. The patent contains 12 claims.
What changed
USPTO issued patent grant US12589119B2 to Fibrobiologics, Inc. for methods of treating cachexia using immune-modulating fibroblast compositions. The patent, with application number 17309177 filed November 4, 2019, contains 12 claims covering the therapeutic compositions and methods of administration. CPC classifications include A61K 35/33, A61P 21/00, and A61P 1/14.
This is a routine patent grant notice providing intellectual property rights rather than regulatory obligations. No compliance actions, deadlines, or penalties are associated with this document. Entities developing similar fibroblast-based cachexia treatments should review the patent claims to assess potential infringement considerations.
Archived snapshot
Mar 31, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Treatment of cachexia using fibroblast cells and products thereof
Grant US12589119B2 Kind: B2 Mar 31, 2026
Assignee
FIBROBIOLOGICS, INC.
Inventors
Pete O'Heeron, Thomas Ichim
Abstract
Disclosed are methods and compositions related to treatment, amelioration or prevention of cachexia or inflammation related to cachexia in a subject. As disclosed, cachexia or inflammation related to cachexia can be treated, ameliorated or prevented by the administration of an effective amount of a composition including immune-modulating fibroblasts to the subject.
CPC Classifications
A61K 35/33 A61P 21/00 A61P 1/14
Filing Date
2019-11-04
Application No.
17309177
Claims
12
Named provisions
Related changes
Get daily alerts for USPTO Patent Grants - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.